Harrow Health, Inc.HROWNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank71
3Y CAGR+13.1%
5Y CAGR+12.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+13.1%/yr
vs +11.0%/yr prior
5Y CAGR
+12.7%/yr
Consistent
Acceleration
+2.1pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.61 | +10.4% |
| 2024 | 5.99 | +113.5% |
| 2023 | 2.81 | -38.7% |
| 2022 | 4.58 | +43.4% |
| 2021 | 3.19 | -12.2% |
| 2020 | 3.63 | -5.6% |
| 2019 | 3.85 | +27.7% |
| 2018 | 3.01 | +137.7% |
| 2017 | 1.27 | -20.6% |
| 2016 | 1.60 | - |